T1	Participants 128 195	previously untreated patients with extensive small cell lung cancer
T2	Participants 198 288	One hundred and eleven previously untreated patients with extensive small cell lung cancer
T3	Participants 518 623	Ninety-six patients were evaluable for response and toxicity and additional 12 patients for toxicity only
